MetaVia Inc. — Director's Dealing 2017

Feb 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2017-02-01

Reporting Person: KOUSKY KENNETH W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-01	Common Stock	J	101406	—	Disposed	4472	Indirect
2017-02-01	Common Stock	J	110428	—	Disposed	6463	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Direct

Footnotes

F1: The transaction on this line represents a pro rata distribution by BWA Gemphire Investment Group, LLC ("BWA") to its members without consideration.

F2: Mr. Kousky, as the Manager of BWA, beneficially owns the reported securities indirectly.

F3: The transaction on this line represents a pro rata distribution by BWA Gemphire Investment Group II, LLC ("BWA II") to its members without consideration.

F4: Mr. Kousky, as the Manager of BWA II, beneficially owns the reported securities indirectly.